Guideline recommends buprenorphine or methadone as first-line treatment for opioid use disorder (high certainty)

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-03-01
DOI
https://doi.org/10.7326/annals-25-00162-jc
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Guideline recommends buprenorphine or methadone as first-line treatment for opioid use disorder (high certainty)

Scott Selinger
2 links
Annals of Internal Medicine
Opioid Use Disorder Treatment
article

Guideline recommends buprenorphine or methadone as first-line treatment for opioid use disorder (high certainty)

Scott Selinger
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(3)
The University of Texas at Austin (US)
Zero hunger
Openalex Percentile: Top 94%
Opioid Use Disorder Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Guideline recommends buprenorphine or methadone as first-line treatment for opioid use disorder (high certainty) — Scott Selinger · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS